Search results for "Androgen"

showing 10 items of 326 documents

Effects of testosterone and β-glucan on immune functions in tench

2005

A hormone manipulation was performed to examine the effects of testosterone on basal and β-glucan-induced immune functions in wild-caught male and female tench Tinca tinca. Testosterone administration elevated testosterone concentration in plasma, but did not suppress lytic activity of plasma or the chemiluminescence response of blood or head kidney phagocytes in any of the three successive samples or in any of the treatment groups. Both testosterone and β-glucan administrations had a negative effect on the relative mass of the spleen, and testosterone-treated fish lost more mass than control fish. Males had a relatively larger spleen than females, but there were no gender differences in im…

chemistry.chemical_classificationmedicine.medical_specialtyHead KidneyPhagocytemedicine.drug_classSpleenTestosterone (patch)Aquatic ScienceBiologyAndrogenBasal (phylogenetics)Endocrinologymedicine.anatomical_structureImmune systemchemistryInternal medicinemedicineEcology Evolution Behavior and SystematicsGlucanJournal of Fish Biology
researchProduct

PCOS Phenotypes: Impact on Fertility

2018

Polycystic ovary syndrome (PCOS) is characterised by an extreme heterogeneity and at least four main phenotypes may be distinguished. In referred population, anovulatory hyperandrogenic phenotype (classic PCOS or phenotypes A and B) is by far the most common phenotype and presents the most severe endocrine and metabolic alterations. Ovulatory PCOS and normoandrogenic phenotype represent a mild form of PCOS that is more common in general population and/or (normoandrogenic) in some particular ethnic group. During their life, because of changes in lifestyle or because of spontaneous changes in ovarian and adrenal androgen secretion that occur during late reproductive age, patients may move fro…

education.field_of_studyendocrine system diseasesbusiness.industrymedia_common.quotation_subjectPopulationnutritional and metabolic diseasesPhysiologyFertilityReproductive agePolycystic ovaryPhenotypefemale genital diseases and pregnancy complicationsAndrogen secretionEndocrine systemMedicineMild formbusinesseducationmedia_common
researchProduct

Generation of homozygosity and genome fixation in pea (Pisum sativum L.)

2013

Pea cultivars are nearly homozygous and thus homogeneous when they are released. The traditional method of selfing is slow and inefficient, taking up to ten generations of inbreeding following a cross to achieve a high level of homozygosity. Current single-seed-descent (SSD) methodologies enable a maximum of three generations per year to be developed in pea. Doubled haploidy and an in vitro based modified SSD technology have been utilised in many important crops for the rapid achievement of homozygosity, and thus acceleration of the breeding process. In pea, due to the lack of robust protocols, none of these technologies is routinely used in a breeding program. The aim of this study was to …

elicitorflurprimidolflow cytometrygibberellinsrelative nuclear DNA contentmicrosporesacceleration of development[SDV] Life Sciences [q-bio]spectral composition of radiationbreedingenhancerandrogenegisPisum sativumbiotechnology
researchProduct

Serum miRNAs in women affected by hyperandrogenic polycystic ovary syndrome: the potential role of miR-155 as a biomarker for monitoring the estropro…

2018

MicroRNAs can be used as very efficient circulating biomarkers. The role of microRNAs in polycystic ovary syndrome (PCOS) and the effects of antiandrogen therapy on microRNA expression is still not fully understood. A panel of serum microRNAs were retrotranscribed via looped reverse primer transcription specific for each miRNA and quantified via probe specific RT-PCR in 16 Caucasian hyperandrogenic PCOS women selected according to the Rotterdam criteria and in a subset of seven patients after four months of sequential reverse antiandrogenic therapy. All women recruited underwent an oral glucose tolerance test (OGTT) and a baseline total cholesterol, high density lipoproteins cholesterol, tr…

endocrine system diseasesEndocrinology Diabetes and Metabolism030209 endocrinology & metabolismurologic and male genital diseasesSettore MED/13 - EndocrinologiamiR-155mir-15503 medical and health sciences0302 clinical medicineEndocrinologymicroRNAMedicineHumansAntiandrogen Therapy030219 obstetrics & reproductive medicineantiandrogenic therapy; biomarker; mir-155; Polycystic ovary syndrome; visceral adipose index; Endocrinology Diabetes and Metabolism; Endocrinology; Obstetrics and Gynecologybusiness.industryantiandrogenic therapyfungifood and beveragesObstetrics and GynecologyAndrogen Antagonistsvisceral adipose indexPolycystic ovaryCirculating biomarkersMicroRNAsCancer researchBiomarker (medicine)biomarkerFemalebusinesshormones hormone substitutes and hormone antagonistsBiomarkersPolycystic Ovary SyndromeGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

The non-aromatizable androgen dihydrotestosterone (DHT) facilitates sexual behavior in ovariectomized female rats primed with estradiol

2020

Abstract It is still unclear whether Testosterone (T) increases sexual desire through a stimulation of the androgen receptor in relevant brain regions or through its conversion to estrogens. The aim of this study was to clarify the mechanisms of T facilitation of female sexual desire by assessing the effect of a non-aromatizable androgen (Dihydrotestosterone, DHT) in a validated animal model. Ovariectomized (OVX) Long-Evans rats were treated with oil (O) + O, 10 mcg Estradiol Benzoate (EB) + O, 10 mcg EB + 500 mcg Progesterone (P), O + 500 mcg DHT or 10 mcg EB + 500 mcg DHT (n = 12 per group). EB was administered 48 h, while P and DHT 4 h, prior to 4 sexual behavioral testing sessions in bi…

endocrine systemmedicine.medical_specialtyLordosismedicine.drug_classEndocrinology Diabetes and MetabolismOvariectomyReceptivitySolicitationSettore BIO/09 - Fisiologia03 medical and health scienceschemistry.chemical_compoundSexual Behavior Animal0302 clinical medicineEndocrinologyInternal medicineSexual desiremedicineAnimalsRats Long-EvansBiological PsychiatryTestosteroneProgesteroneEstradiolEndocrine and Autonomic SystemsChemistryEstrogensDihydrotestosteroneAndrogenmedicine.diseasePreclinical030227 psychiatryRatsAndrogen receptorPsychiatry and Mental healthEndocrinologyDihydrotestosteroneOvariectomized ratEstradiol benzoateAndrogenssexual behavior female ratRatFemaleProgestinshormones hormone substitutes and hormone antagonists030217 neurology & neurosurgerymedicine.drug
researchProduct

Hypothalamic-Pituitary-Adrenal Dysfunction in the Polycystic Ovary Syndrome

2007

Between 20 and 30% of patients with polycystic ovary syndrome (PCOS) demonstrate adrenal androgen (AA) excess, detectable primarily by elevated dehydroepiandrosterone sulfate (DHEAS) levels. Generalized adrenocortical hyperresponsivity to adrenocorticotropic hormone (ACTH) stimulation is also observed and may be the principal mechanism determining AA excess in PCOS. The causes of this abnormality are unclear, but increased peripheral metabolism of cortisol, altered factors regulating glucose-mediated glucose disposal, and perhaps ovarian sex steroids may in different ways contribute to the AA excess in PCOS. Additionally, DHEAS levels and the response of AAs to ACTH are relatively constant …

endocrine systemmedicine.medical_specialtybusiness.industrymedicine.drug_classHyperandrogenismStimulationAdrenocorticotropic hormoneMetabolismAndrogenmedicine.diseasePolycystic ovaryPeripheralchemistry.chemical_compoundEndocrinologyDehydroepiandrosterone sulfatechemistryInternal medicineMedicinebusinesshormones hormone substitutes and hormone antagonists
researchProduct

Ovarian size and blood flow in women with polycystic ovary syndrome (PCOS) and their correlations with some endocrine parameters

2005

Objective: To determine how common polycystic ovarian morphology may be in women given the clinical diagnosis of polycystic ovary syndrome (PCOS) based on chronic anovulation and hyperandrogenism and whether certain hormonal factors correlate with ovarian morphology and blood flow. Design: Prospective study. Setting: Two academic endocrinology centers in Italy. Patient(s): Three hundred twenty-six women with PCOS and 50 age-matched and weight-matched ovulatory women. Intervention(s): Ultrasound assessment of ovarian morphology in patients and controls and ovarian blood flow and fasting hormone levels in a subset of 50 patients and matched controls. Main Outcome Measure(s): Ovarian morpholog…

endocrine systemmedicine.medical_specialtyendocrine system diseasesmedicine.drug_classPolycystic ovary syndrome ovarian size blood flow insulin testosterone inhibin Bmedicine.medical_treatmentHemodynamicsOvaryBiologyStatistics NonparametricAnovulationInsulin resistanceEndocrine GlandsInternal medicinemedicineHumansProspective StudiesGonadal Steroid Hormonesendocrine parametersAnalysis of VarianceInsulinOvaryHyperandrogenismObstetrics and GynecologyOrgan Sizemedicine.diseasePolycystic ovaryfemale genital diseases and pregnancy complicationsmedicine.anatomical_structureEndocrinologyReproductive MedicineRegional Blood FlowEstrogenpolycystic ovary syndromeFemaleHyperandrogenismpolycystic ovary syndrome; endocrine parametersAnovulation
researchProduct

Clinical and metabolic findings in a 6-year-old boy with a Leydig cell tumour

2011

Aim:  To analyse the urinary steroid metabolome in a boy who had true precocious puberty after a Leydig cell tumour. Method:  Case report and detailed description of clinical and metabolic findings in a 7-year-old-boy with a Leydig cell tumour. Results:  Before surgery, the urinary steroid metabolome showed an activation of an alternative route to gonadal androgens independent of dehydroepiandrosterone (DHEA). After surgery, the boy entered true precocious puberty. Under leuprolide acetate treatment, clinical and laboratory findings normalized. Conclusion:  Central precocious puberty after precocious pseudopuberty may be more common than expected and should be considered in children with pe…

endocrine systemmedicine.medical_specialtymedicine.drug_classbusiness.industryUrinary systemCentral precocious pubertyDehydroepiandrosteroneGeneral MedicineAndrogenLeydig cell tumourmedicine.diseasePrecocious pseudopubertyBack doorEndocrinologyInternal medicinePediatrics Perinatology and Child HealthmedicineMetabolomebusinessActa Paediatrica
researchProduct

Effect of Cetrorelix on sperm morphology during migration through the epididymis in the cynomolgus macaque (Macaca fascicularis)

2000

The importance of the cynomolgus monkey as a model for human reproductive medicine prompted this examination of epididymal sperm morphology. Computer-aided sperm morphological analysis was used for the first time to provide morphometric data on sperm heads as they traversed the epididymal duct of Macaca fascicularis. The duct was divided into six regions, starting close to the testis (proximal) and ending close to the vas deferens (distal). To determine the androgen-dependence of the changes, one group of animals received a GnRH-antagonist (Cetrorelix, Asta Medica, Frankfurt, Germany) to induce testicular regression and lower epididymal androgens, while a control group received only vehicle…

endocrine systemurogenital systemmedicine.drug_classVas deferensSemenAnatomyGonadotropin-releasing hormoneBiologyAndrogenEpididymisSpermmedicine.anatomical_structuremedicineAnimal Science and ZoologyTesticular RegressionEcology Evolution Behavior and SystematicsSperm motilityAmerican Journal of Primatology
researchProduct

Effects of combined hormone replacement therapy or its effective agents on the IGF-1 pathway in skeletal muscle.

2010

Objectives To investigate the effects of combined hormone replacement therapy (HRT) and its effective agents on the IGF-1 signaling pathway. Design and methods To examine the effects of HRT on skeletal muscle in vivo, we utilized pre- and post-intervention samples from a randomized double blinded trial with 50–57-year-old women. The intervention included the year-long use of either HRT preparation (2 mg 17β-estradiol, E2; 1 mg norethisterone acetate, NETA, n = 10) or placebo (CO, n = 9). Microarray technology and quantitative PCR (qPCR) were used to study the expression of insulin-like growth factor I (IGF-1) and its splice variants as well as IGF-1 receptor, Akt1, mTOR, FOXO1, FOXO3, atrog…

estradioliTranscription GeneticEndocrinology Diabetes and MetabolismMuscle Fibers SkeletalEstrogen receptorpostmenopausal womenMuscle ProteinsFOXO1Receptor IGF Type 10302 clinical medicineEndocrinologyProtein IsoformsTestosteroneInsulin-Like Growth Factor IReceptorRandomized Controlled Trials as Topic0303 health sciencesEstradiolMyogenesisForkhead Box Protein O1TOR Serine-Threonine KinasesEstrogen Replacement TherapyForkhead Box Protein O3Forkhead Transcription FactorsMiddle Agedmedicine.anatomical_structureReceptors EstrogenReceptors AndrogenFemalemedicine.medical_specialtynorethisterone acetate030209 endocrinology & metabolismBiologypostmenopausaalinen nainen03 medical and health sciencesInternal medicinemedicineHumansnoretisteroniasetaattiluurankolihasskeletal muscleMuscle SkeletalProtein kinase BPI3K/AKT/mTOR pathway030304 developmental biologyhormonikorvaushoitoSKP Cullin F-Box Protein LigasesSkeletal muscleAndrogen receptorNorethindrone AcetateEndocrinologyHormone replacement therapyIGF-1 signalointiNorethindroneIGF-1 signalingProto-Oncogene Proteins c-aktGrowth hormoneIGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society
researchProduct